Relationship of tumor size to survival in patients with pT2N0 lung cancer.

about

Relationship of tumor size to survival in patients with pT2N0 lung cancer.

Item

http://www.wikidata.org/entity/Q47352301

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Relationship of tumor size to survival in patients with pT2N0 lung cancer.

@en

Relationship of tumor size to survival in patients with pT2N0 lung cancer.

@nl

type

Item

label

Relationship of tumor size to survival in patients with pT2N0 lung cancer.

@en

Relationship of tumor size to survival in patients with pT2N0 lung cancer.

@nl

prefLabel

Relationship of tumor size to survival in patients with pT2N0 lung cancer.

@en

Relationship of tumor size to survival in patients with pT2N0 lung cancer.

@nl

P1476

Relationship of tumor size to survival in patients with pT2N0 lung cancer.

@en

P2093

Hitoshi Ueda

http://www.w3.org/2001/XMLSchema#string

Ichiro Yoshino

http://www.w3.org/2001/XMLSchema#string

Kaoru Ondo

http://www.w3.org/2001/XMLSchema#string

Ryuichi Suemitsu

http://www.w3.org/2001/XMLSchema#string

Yasunori Shikada

http://www.w3.org/2001/XMLSchema#string

Yoshihiko Maehara

http://www.w3.org/2001/XMLSchema#string

P2860

Revisions in the International System for Staging Lung Cancer

Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease.

T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer.

A system for the clinical staging of lung cancer.

Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer.

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJS

P304

30-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/021849230601400108

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16432115

http://www.w3.org/2001/XMLSchema#string